These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Dyslipidemia-associated alterations in B cell subpopulation frequency and phenotype during experimental atherosclerosis. Rincón-Arévalo H; Castaño D; Villa-Pulgarín J; Rojas M; Vásquez G; Correa LA; Ramírez-Pineda JR; Yassin LM Atherosclerosis; 2016 Apr; 247():118-26. PubMed ID: 26897258 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice. Shemesh S; Kamari Y; Shaish A; Olteanu S; Kandel-Kfir M; Almog T; Grosskopf I; Apte RN; Harats D Atherosclerosis; 2012 Jun; 222(2):329-36. PubMed ID: 22236482 [TBL] [Abstract][Full Text] [Related]
13. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation. Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036 [TBL] [Abstract][Full Text] [Related]
14. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Pan L; Sato S; Frederick JP; Sun XH; Zhuang Y Mol Cell Biol; 1999 Sep; 19(9):5969-80. PubMed ID: 10454544 [TBL] [Abstract][Full Text] [Related]
15. IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice. Mantani PT; Dunér P; Bengtsson E; Alm R; Ljungcrantz I; Söderberg I; Sundius L; To F; Nilsson J; Björkbacka H; Fredrikson GN PLoS One; 2015; 10(1):e0117255. PubMed ID: 25629516 [TBL] [Abstract][Full Text] [Related]
16. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice. Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487 [TBL] [Abstract][Full Text] [Related]
17. Deficiency of a transcriptional regulator, inhibitor of differentiation 3, induces glomerulonephritis in apolipoprotein E-deficient mice: a model linking hyperlipidemia and renal disease. Bagavant H; Scindia Y; Nackiewicz D; Nandula SR; Doran A; Cutchins A; Oldham S; Deshmukh U; McNamara C Am J Pathol; 2011 Aug; 179(2):651-60. PubMed ID: 21801865 [TBL] [Abstract][Full Text] [Related]
18. Protective Role for B-1b B Cells and IgM in Obesity-Associated Inflammation, Glucose Intolerance, and Insulin Resistance. Harmon DB; Srikakulapu P; Kaplan JL; Oldham SN; McSkimming C; Garmey JC; Perry HM; Kirby JL; Prohaska TA; Gonen A; Hallowell P; Schirmer B; Tsimikas S; Taylor AM; Witztum JL; McNamara CA Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):682-91. PubMed ID: 26868208 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-21-mediated suppression of the Pax3-Id3 pathway exacerbates the development of Sjögren's syndrome via follicular helper T cells. Park JS; Kim SM; Choi J; Jung KA; Hwang SH; Yang S; Kwok SK; Cho ML; Park SH Cytokine; 2020 Jan; 125():154834. PubMed ID: 31491724 [TBL] [Abstract][Full Text] [Related]
20. Loss of Id3 (Inhibitor of Differentiation 3) Increases the Number of IgM-Producing B-1b Cells in Ischemic Skeletal Muscle Impairing Blood Flow Recovery During Hindlimb Ischemia. Osinski V; Srikakulapu P; Haider YM; Marshall MA; Ganta VC; Annex BH; McNamara CA Arterioscler Thromb Vasc Biol; 2022 Jan; 42(1):6-18. PubMed ID: 34809449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]